Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-123,900
Closed -$35.6M 128
2024
Q3
$35.6M Sell
123,900
-50,200
-29% -$15.8M 0.65% 47
2024
Q2
$54.6M Hold
174,100
1.08% 30
2024
Q1
$58.5M Buy
174,100
+41,900
+32% +$12.4M 1.07% 30
2023
Q4
$37.4M Hold
132,200
0.75% 45
2023
Q3
$32.6M Buy
+132,200
New +$33.3M 0.69% 55

Other funds holding ICLR

OrbiMed's ICLR Position: Q4 2024 in Review

OrbiMed sold out of Icon (ICLR) in Q4 2024, closing a stake of 123,900 shares — an estimated $35.6M sold.

OrbiMed first reported a position in ICLR in Q3 2023 and held it in 5 quarters. The position peaked at $58.5M in Q1 2024. 595 funds tracked by Wall St. Rank hold ICLR as of Q4 2024.

  • OrbiMed reported no remaining Icon position as of Q4 2024 after selling out during the quarter.
  • OrbiMed sold 123,900 Icon shares in Q4 2024, an estimated $35.6M.
  • OrbiMed first reported a position in Icon in Q3 2023 and held it in 5 quarters.
  • OrbiMed's Icon position peaked at $58.5M in Q1 2024.
  • 595 funds tracked by Wall St. Rank held Icon as of Q4 2024.

Based on OrbiMed's 13F filing for Q4 2024, filed 14 Feb 2025.